[9]
Kobayashi, K.; Endoh, F.; Ohmori, I.; Akiyama, T. Action of antiepileptic drugs on neurons. Brain Dev., 2020, 42(1), 2-5.
[32]
Pitkänen, A.; Kharatishvili, I.; Karhunen, H.; Lukasiuk, K.; Immonen, R.; Nairismägi, J.; Gröhn, O.; Nissinen, J. Epileptogenesis in experimental models. Epilepsia, 2007, 48(Suppl. 2), 13-20.
[33]
Jayalakshmi, S.; Vooturi, S.; Sahu, S.; Yada, P.K.; Mohandas, S. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy. J. Clin. Neurosci., 2016, 26, 89-94.
[43]
Löscher, W. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology, 2020, 167107605
[55]
Patel, DC; Wallis, G; Dahle, EJ; McElroy, PB; Thomson, KE; Tesi, RJ; Szymkowski, DE; West, PJ; Smeal, RM; Patel, M; Fujinami, RS; White, HS; Wilcox, KS Hippocampal TNFα signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. eNeuro,, 2017, 4(2) pii: ENEURO, , 0105-17.
[84]
Yoshida, S; Hong, S; Suzuki, T; Nada, S; Mannan, AM; Wang, J; Okada, M; Guan, KL; Inoki, K Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway. J Biol Chem, 201, 286(37), 32651-32660.
[94]
Jozwiak, S.; Słowińska, M.; Borkowska, J.; Sadowski, K.; Łojszczyk, B.; Domańska-Pakieła, D.; Chmielewski, D.; Kaczorowska-Frontczak, M.; Głowacka, J.; Sijko, K.; Kotulska, K. Preventive antiepileptic treatment in tuberous sclerosis complex: a long-term, prospective trial. Pediatr. Neurol., 2019, 101, 18-25.
[95]
Santos, D.; Giudetti, G.; Micera, S.; Navarro, X.; Del Valle, J.; Domańska-Pakieła, D.; Chmielewski, D.; Kaczorowska-Frontczak, M.; Głowacka, J.; Sijko, K.; Kotulska, K. Focal release of neurotrophic factors by biodegradable microspheres enhance motor and sensory axonal regeneration in vitro and in vivo. Brain Res., 2016, 1636, 93-106.